Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NeOnc Technologies Holdings, Inc. ( (NTHI) ) just unveiled an update.
On October 28, 2025, NeOnc Technologies Holdings, Inc. announced that His Highness Sheikh Nahyan bin Zayed Al Nahyan will assume the role of Executive Chairman of NuroMENA Holdings Ltd., its Middle East subsidiary. This strategic move is expected to significantly impact the company’s operations and position the UAE at the forefront of brain cancer treatment innovation, leveraging sovereign resources to address global health challenges.
More about NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company specializing in the development and commercialization of central nervous system therapeutics. The company focuses on overcoming the blood-brain barrier with its NEO™ drug development platform, which has produced a portfolio of novel drug candidates and delivery methods. These include NEO100™ and NEO212™, which are in Phase II human clinical trials and have FDA Fast-Track and IND status. NeOnc has an extensive patent portfolio licensed from the University of Southern California.
Average Trading Volume: 78,152
Technical Sentiment Signal: Strong Buy
Current Market Cap: $185.3M
See more data about NTHI stock on TipRanks’ Stock Analysis page.